Archives
- 2026-09
- 2026-08
- 2026-07
- 2026-06
- 2026-05
- 2026-04
- 2026-03
- 2026-02
- 2026-01
- 2025-12
- 2025-11
- 2025-10
- 2025-09
- 2025-04
- 2025-03
- 2025-02
- 2025-01
- 2024-12
- 2024-11
- 2024-10
- 2024-09
- 2024-08
- 2024-07
- 2024-06
- 2024-05
- 2024-04
- 2024-03
- 2024-02
- 2024-01
- 2023-12
- 2023-11
- 2023-10
- 2023-09
- 2023-08
- 2023-06
- 2023-05
- 2023-04
- 2023-03
- 2023-02
- 2023-01
- 2022-12
- 2022-11
- 2022-10
- 2022-09
- 2022-08
- 2022-07
- 2022-06
- 2022-05
- 2022-04
- 2022-03
- 2022-02
- 2022-01
-
CXCL1-CXCR2 Signaling in Pancreatic Cancer Pain
2026-09-01
This study identifies the nucleus tractus solitarii as a central site where CXCL1-CXCR2 signaling activates microglia and amplifies pancreatic cancer-induced pain. Its combination of transcriptomics, behavioral testing, localized pharmacology, and gain- and loss-of-function experiments provides a mechanistic framework for studying brainstem neuroinflammation in visceral cancer pain.
-
Bsa I (RNase-free): Practical Workflow Guide
2026-09-01
Bsa I (RNase-free) provides sequence-directed DNA cleavage for cloning and other molecular biology research workflows in which control of RNase contamination is important. It is intended for scientific research only, not diagnostic, clinical, or medical use, and reaction conditions should be validated for each DNA substrate.
-
Midecamycin: Reading MIC Data by Mechanism
2026-08-31
Midecamycin is an acetoxy-substituted macrolide antibiotic whose ribosomal targeting and selective activity make it valuable for antibiotic research. This article connects chemical structure, historical MIC methods, resistance interpretation, and assay design into a practical framework for microbiology studies.
-
Angiotensin I/II (1-5) Workflow Guide
2026-08-31
Angiotensin I/II (1-5) provides a defined Asp-Arg-Val-Tyr-Ile peptide fragment for controlled renin-angiotensin system research involving blood pressure regulation and aldosterone release stimulation. It is suited to cardiovascular and renal workflows, but its water insolubility and lack of clinical validation limit use in unrelated signaling studies or therapeutic interpretation.
-
Q-VD-OPh for Caspase Recovery Assays
2026-08-30
Q-VD-OPh is a cell-permeable pan-caspase inhibitor for separating caspase-driven death from post-stress recovery, anastasis, and assay-specific toxicity. This workflow combines controlled inhibitor exposure, orthogonal viability measurements, and the latest kinase-screen findings to improve apoptosis research, cryopreservation studies, and neurodegenerative disease experiments.
-
Novobiocin: From Target Biology to Translation
2026-08-29
Novobiocin is more than a conventional antimicrobial screening reagent. As an aminocoumarin antibiotic, it links bacterial DNA gyrase B ATPase inhibition with Hsp90 modulation and offers a strategically useful platform for antibacterial resistance research, antiparasitic studies, and selected antiviral workflows. This thought-leadership article connects mechanism, assay design, exposure planning, and translational decision-making while distinguishing established evidence from practical next steps.
-
In Vitro Activity of Midecamycin: 1983 Study Review
2026-08-28
Harold C. Neu’s 1983 study established an early comparative profile for Midecamycin, an acetoxy-substituted macrolide antibiotic, across clinically derived Gram-positive and Gram-negative isolates. The results showed useful activity against many streptococci, staphylococci, Haemophilus influenzae, and Listeria, but lower potency than erythromycin and no meaningful activity against erythromycin-resistant isolates or most tested Gram-negative bacilli.
-
Amorolfine Hydrochloride in Yeast Integrity Assays
2026-08-28
Use Amorolfine Hydrochloride as a controlled membrane-stress probe in yeast ploidy, viability, and antifungal mechanism studies. This workflow connects cell-size limits with fungal cell membrane disruption while emphasizing solvent control, fresh solutions, and assay-specific optimization.
-
Sodium Oxamate: Beyond a Glycolysis Blocker
2026-08-27
Sodium Oxamate is more than a Warburg effect inhibitor: it is a powerful tool for separating glycolytic flux, lactate signaling, and histone lactylation. This article examines how a recent intracerebral hemorrhage study changes experimental interpretation and assay design.
-
T0070907 as a Causal Probe of PPARγ Signaling
2026-08-27
T0070907 is a high-affinity PPARγ antagonist for dissecting receptor-dependent transcription, adipogenesis, and cell-cycle phenotypes. This article translates recent RXRα/PPARγ/NEDD4 findings into a practical assay strategy that distinguishes pathway correlation from causation.
-
Cyanidin Chloride: Identity-to-Barrier Assay Design
2026-08-26
Cyanidin Chloride can connect reactive oxygen species scavenging with inflammatory and epithelial-barrier endpoints, but only when chemical identity is verified. This guide develops an identity-aware workflow for oxidative stress research using orthogonal assays and careful interpretation of related cyanin chloride evidence.
-
ECL Western Blotting Substrate Workflow
2026-08-26
ECL Western Blotting Substrate (SKU K2187) provides luminol-based, nonradioactive detection of HRP-conjugated proteins on immunoblots, with signal capture by X-ray film or CCD imaging. It is intended for HRP chemiluminescence workflows and should not be used as a fluorescent or radioisotopic detection reagent.
-
Mianserin HCl: 5-HT2 Antagonist Research Guide
2026-08-25
Mianserin HCl is a tetracyclic antidepressant research compound with noradrenergic activity and 5-HT2 receptor antagonism. Its cyclodextrin complexes have measurable binding and can increase cytotoxicity in cell assays, so formulation effects must be separated from intrinsic receptor pharmacology.
-
Talabostat Mesylate: Research Workflows
2026-08-25
Talabostat mesylate (PT-100) supports two complementary research directions: pharmacologic interrogation of keratinocyte NLRP1 responses and mechanistic studies of DPP4/FAP biology in cancer models. This practical guide covers model selection, dosing, assay controls, optimization, and the limitations that determine whether results are reproducible.
-
GSK343: Reliable EZH2 Inhibition in Cell Assays
2026-08-24
A scenario-based guide to using GSK343 (SKU A3449) for EZH2-focused viability, proliferation, and epigenetic cancer research. It connects biochemical potency with cellular H3K27me3 and phenotype readouts while addressing formulation, controls, interpretation, and vendor-selection decisions.